| Posttranslational modification of the Ha-ras oncogene protein: evidence for a third class of protein carboxyl methyltransferases. | None |
| A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome. | None |
| Activation of H-ras oncogene in 3-methylcholanthrene-transformed human cell line. | None |
| Antibodies against synthetic carboxy-terminal peptides distinguish H-ras and K-ras oncogene products p21. | None |
| Novel source of 1,2-diacylglycerol elevated in cells transformed by Ha-ras oncogene. | None |
| Morphological transformation and tumorigenicity in C3H/10T1/2 cells transformed with an inducible c-Ha-ras oncogene. | None |
| Serum levels of c-myc and c-ras oncogene products in normal subjects and in patients with neoplastic and non neoplastic conditions. | None |
| Involvement of functional protein kinase C in the mitogenic response to the H-ras oncogene product. | None |
| Induction of neurite formation in PC12 cells by microinjection of proto-oncogenic Ha-ras protein preincubated with guanosine-5 -O-(3-thiotriphosphate). | None |
| Molecular-genetic analysis of myc and c-Ha-ras proto-oncogene alterations in human carcinoma. | None |
| NIH-3T3 cells expressing high levels of the c-ras proto-oncogene display reduced platelet derived growth factor-stimulated phospholipase activity. | None |
| Enhanced expression of Harvey-ras oncogene in FANFT-induced transitional cell carcinoma. | None |
| Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice. | None |
| HRAS1-selected, chromosome mediated gene transfer; in situ hybridization with combined biotin and tritium label localizes the oncogene and reveals duplications of the human transgenome. | None |
| Deletion analysis of the c-Ha-ras oncogene promoter. | None |
| The human T24 Ha-ras1 oncogene: a study of the effects of overexpression of the mutated ras gene product in rodent cells. | None |
| Inhibition of H-ras oncogene transformation of NIH3T3 cells by protease inhibitors. | None |
| Expression of Ha-ras oncogene product in rat gastrointestinal carcinomas induced by chemical carcinogens. | None |
| Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene. | None |
| Expression of Ha-ras oncogene p21 protein in relation to the cell cycle of cultured human tumor cells. | None |